Capecitabine
Links shared publicly online about this topic
NICE Draft Guidance Recommends Capecitabine For Advanced Gastric Cancer
medicalnewstoday.com — “In draft guidance published, NICE has recommended a new treatment for advanced gastric cancer. Capecitabine (Xeloda, Roche Products) is recommended, in combination with a platinum-based regimen, f” View full resource at medicalnewstoday.com
Most Recently Shared on May 28, 2010 at 4:11 pm By:
MNT Gastrointestinal Health News
NICE Draft Guidance Recommends Capecitabine For Advanced Gastric Cancer http://mnt.to/3DfH #gastrointestinal
Gastroenterology Article | Use of capecitabine in management of early colon cancer
mdlinx.com — “Use of capecitabine in management of early colon cancer” View full resource at mdlinx.com
Most Recently Shared on September 21, 2011 at 7:52 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Use of capecitabine in management of early colon cancer: Cancer Management and Research http://t.co/18VS5ADM #GI
Effects of chemoradiation therapy by using capecitabine on gastric cancer patients
physorg.com — “A research team from Singapore reviewed the outcome of patients with resected gastric cancers treated with capecitabine and radiation compared to 5-fluorouracil with radiation or fluoropyrimidine-based chemotherapy only. They found that survival of patients treated with capecitabine and radiation was ...” View full resource at physorg.com
Most Recently Shared on September 20, 2010 at 5:30 pm By:
PhysOrg Health News Health News
Effects of chemoradiation therapy by using capecitabine on gastric cancer patients http://tw.physorg.com/204200642
NHS Evidence - Gastroenterology and liver diseases - Capecitabine for the treatment of advanced gastric cancer
library.nhs.uk — “Aims: This technology appraisal addresses the use of capecitabine for the treatment of advanced gastric cancer. Recommendations: Capecitabine in combination with a platinum-based regimen is recommended for the first-line treatment of inoperable advanced gastric cancer. Intended audience: Healthcare professionals. Methodology and Development: Section 4 'Consideration of the evidence' addresses the clinical and cost effectiveness of capecitabine for the treatment of advanced gastric cancer, and co” View full resource at library.nhs.uk
Most Recently Shared on July 31, 2010 at 11:48 pm By:
Capecitabine for the treatment of advanced gastric cancer: Aims: This technology appraisal addresses the use of ca... http://bit.ly/a1kerF
Study shows capecitabine with concurrent radiation effective for gastric cancer
news-medical.net — “Gastric cancer is a major cause of cancer deaths in the world. The outcome of large gastric tumors and those with lymph node involvement remains poor after surgical resection. The optimal adjuvant therapy after surgical resection remains to be determined. The most common strategies in the adjuvant treatment of gastric cancers include fluoropyrimidine-based chemotherapy with or without radiation. The introduction of capecitabine has largely replaced continuous-infusion 5-fluorouracil (5-FU) owing” View full resource at news-medical.net
Most Recently Shared on September 21, 2010 at 5:48 am By:
Study shows capecitabine with concurrent radiation effective for gastric cancer: Gastric cancer is a major cause o... http://bit.ly/9S8BvO
Combination Therapy of Lapatinib and Capecitabine ... [Onkologie. 2011] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on May 29, 2011 at 1:20 pm By:
Combination Therapy of Lapatinib and Capecitabine forErbB2-Positive Metastatic or Locally Advanced BreastCancer:... http://bit.ly/k55z5X
ingentaconnect Capecitabine/phenytoin interaction: Increased phenytoin concentra...
ingentaconnect.com — “ingentaconnect Capecitabine/phenytoin interaction: Increased phenytoin concentra...” View full resource at ingentaconnect.com
Most Recently Shared on September 6, 2011 at 8:32 am By:
Capecitabine/phenytoin interaction: Increased phenytoin concentration leading to various toxicities: case report... http://t.co/IcWXDWb
Initiation Of Clinical Trial To Evaluate IL-7 (CYT107) And XELODA (R) (Capecitabine) Combination In Treatment Of Metastatic Breast Cancer
medicalnewstoday.com — “Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, the Centre L©on B©rard (Lyon), the major cancer research and t” View full resource at medicalnewstoday.com
Most Recently Shared on May 11, 2011 at 3:05 pm By:
Initiation Of Clinical Trial To Evaluate IL-7 (CYT107) And XELODA (R) (Capecitabine) Combination In Treatment Of Metas... http://mnt.to/3VJb
Capecitabine or Xeloda and Loss of Fingerprints | MyDocHub Blog - Online Health Community
mydochub.com — “Read about a possible side effect of taking capecitabine or Xeloda, which may include the loss of your fingerprints to ...” View full resource at mydochub.com
Most Recently Shared on May 27, 2009 at 2:06 pm By:
Capecitabine or Xeloda and Loss of Fingerprints: I never thought cancer could erase your fingerprints, but I gue.. http://tinyurl.com/oqeee8
Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell Carcinoma - Renal and Urology News
renalandurologynews.com — “A look at the following clinical trial: Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell Carcinoma” View full resource at renalandurologynews.com
Most Recently Shared on July 14, 2011 at 7:19 pm By:
Renal Urology News Urology, Medical Publisher, Health News, and Nephrology
Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell Carcinoma: A ... http://bit.ly/oeXsR1
Phase II Trial of Simple Oral Therapy with Capecitabine and Cyclophosphamide in Patients with Metastatic Breast Cancer: SWOG S0430
theoncologist.alphamedpress.org — “Phase II Trial of Simple Oral Therapy with Capecitabine and Cyclophosphamide in Patients with Metastatic Breast Cancer: SWOG S0430” View full resource at theoncologist.alphamedpress.org
Most Recently Shared on March 14, 2012 at 7:46 pm By:
Oncology Society Medical Society
Phase II Trial of Simple Oral Therapy with Capecitabine and Cyclophosphamide in Patients with Metastatic Breast Cancer http://t.co/xLdO7JLg
Gastroenterology News - Effect of neoadjuvant cetuximab, capecitabine, and radiotherapy for locally advanced rectal cancer: results of a phase II study |3989963
mdlinx.com — “Gastroenterology Medical Article: Effect of neoadjuvant cetuximab, capecitabine, and radiotherapy for locally advanced rectal cancer: results of a phase II study” View full resource at mdlinx.com
Most Recently Shared on March 22, 2012 at 4:33 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Effect of neoadjuvant cetuximab, capecitabine, and radiotherapy for locally advanced rectal cancer: results ... http://t.co/xTZ3WvTK #GI
Adjuvant Capecitabine and Oxaliplatin for Gastric Cancer: Results of the Phase 3 CLASSIC Trial - ONA
oncologynurseadvisor.com — “Adjuvant capecitabine and oxaliplatin (XELOX) demonstrated superior efficacy when compared with observation alone following D2 gastrectomy for gastric cancer, according to study results presented at the American Society of Clinical Oncology’s 2011 Annual Meeting.” View full resource at oncologynurseadvisor.com
Most Recently Shared on June 7, 2011 at 4:12 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Adjuvant Capecitabine and Oxaliplatin for Gastric Cancer: Results of the Phase 3 CLASSIC Trial http://goo.gl/fb/0oUKs
Ph II data of perifosine + capecitabine in metastatic CRC to be presented at gastrointestinal cancer congress
news-medical.net — “Keryx Biopharmaceuticals, Inc. today announced that abstract O-0017, entitled "Subset Analysis of 5-FU Refractory Patients from a Randomized Ph II Study of Perifosine + Capecitabine (P-CAP) vs. Placebo + Capecitabine (CAP) in Patients with 2nd or 3rd Line Metastatic CRC" has been selected for oral presentation at the upcoming 12th World Congress on Gastrointestinal Cancer, to be held in Barcelona, Spain from June 30 - July 2, 2010.” View full resource at news-medical.net
Most Recently Shared on June 30, 2010 at 6:53 am By:
News-Medical.Net Health News and Oncology
Oncology News: Ph II data of perifosine + capecitabine in metastatic CRC to be presented at gastrointestinal cance... http://bit.ly/cnPPne
Capecitabine Combined With Oxaliplatin (CapOx) in Clinical Practice: How Significant is Peripheral Neuropathy? - QualityPoint Technologies
qualitypointtech.net — “Neurosensory toxic effects of common CRC treatments are quantified in this study evaluating peripheral neuropathies. Annals of Oncology” View full resource at qualitypointtech.net
Most Recently Shared on September 28, 2010 at 4:48 pm By:
Capecitabine Combined With Oxaliplatin (CapOx) in Clinical Practice: How Significant is Peripheral Neuropathy?: Ne... http://bit.ly/94uszR
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
MNT Gastrointestinal
The latest gastrointestinal news published daily. Articles from research centers, universities and prestigious journals.
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
PhysOrg Health News
PhysOrg.com Health and Medicine News Stories
Advertisement
